The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
Open accessAbstract
The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory capacity of the potent synthetic cannabinoid HU210 on hippocampal neurogenesis and its possible correlation with behavioral change. We show that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis. This hypothesis is supported by further findings that HU210 promotes proliferation, but not differentiation, of cultured embryonic hippocampal NS/PCs likely via a sequential activation of CB1 receptors, G(i/o) proteins, and ERK signaling. Chronic, but not acute, HU210 treatment promoted neurogenesis in the hippocampal dentate gyrus of adult rats and exerted anxiolytic- and antidepressant-like effects. X-irradiation of the hippocampus blocked both the neurogenic and behavioral effects of chronic HU210 treatment, suggesting that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal neurogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“This is unlikely, however, as we observed no significant difference in the number of rats climbing (41, 42) among HU210-, AM281-, and vehicle-treated groups in the first 5 minutes of the pretest sessions of the FST.”
BackgroundMethodMilestones of neuronal development in the adult hippocampus
Kempermann, G., Jessberger, S., Steiner, B., & Kronenberg, G. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.013 · Cited by 1,460
Reynolds, B. A., & Weiss, S. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0090 · Cited by 1,368
Gritti, A., Parati, E. A., Cova, L., Frolichsthal, P., Galli, R., Wanke, E., Faravelli, L., Morassutti, D. J., Roisen, F. J., Nickel, D. D., et al. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01091.1996 · Cited by 1,029
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 1,003
Cited by
Sorted by citations
Items 201–300 of 526
Phytocannabinoids and Endocannabinoids
Fišar, Z. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010051 · Cited by 57
Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 59
Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
Bachmeier, C. J., Beaulieu‐Abdelahad, D., MULLAN, M. J., & Paris, D. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.06.004 · Cited by 57
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Zimmermann, T., Maroso, M., Beer, A., Baddenhausen, S., Ludewig, S., Fan, W., Vennin, C., Loch, S., Berninger, B., Hofmann, C., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy258 · Cited by 53
Carr, R. L., Graves, C. A., Mangum, L. C., Nail, C. A., & Ross, M. K. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.12.009 · Cited by 51
Moyse, E., Segura, S., Liard, O., Mahaut, S., & Mechawar, N. (2008) · Current Stem Cell Research & Therapy · doi:10.2174/157488808785740334 · Cited by 53
Rodrigues, R. S., Ribeiro, F. F., Ferreira, F., Vaz, S. H., Sebastião, A. M., & Xapelli, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00516 · Cited by 51
A possible role for the endocannabinoid system in the neurobiology of depression
Serra, G., & Fratta, W. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-25 · Cited by 51
Interleukin-1 beta guides the migration of cortical neurons
Ma, L., Li, X., Zhang, S.-J., Yang, F., Zhu, G., Yuan, X., & Jiang, W. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-114 · Cited by 50
Self-citationBlanco, E., Rivera, P., Arrabal, S., Vargas, A., Pavón, F. J., Serrano, A., Castilla‐Ortega, E., Galeano, P., Rubio, L., Suárez, J., et al. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00106 · Cited by 50
Lee, T. T. ‐., Wainwright, S. R., Hill, M. N., Galea, L. A. M., & Gorzalka, B. B. (2013) · Hippocampus · doi:10.1002/hipo.22221 · Cited by 56
Morrish, A. C., Hill, M. N., Riebe, C. J. N., & Gorzalka, B. B. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.04.023 · Cited by 49
The grass isn’t always greener: The effects of cannabis on embryological development
Friedrich, J., Khatib, D., Parsa, K. M., Santopietro, A., & Gallicano, G. I. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0085-6 · Cited by 49
Sex differences in hippocampal area CA3 pyramidal cells
Scharfman, H. E., & MacLusky, N. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23927 · Cited by 49
Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals
Hartsel, J. A., Boyar, K., Pham, A., Silver, R. J., & Makriyannis, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_10 · Cited by 56
Role of extracellular signal-regulated kinase signal transduction pathway in anxiety
Ailing, F., Fan, L., Li, S., & Manji, S. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.018 · Cited by 48
Synthetic cannabinoids and their impact on neurodevelopmental processes
Alexandre, J., Carmo, H., Carvalho, F. D., & Silva, J. P. (2019) · Addiction Biology · doi:10.1111/adb.12824 · Cited by 50
Oesch, S., Walter, D., Wachtel, M., Prêtre, K., Salazar‐Roa, M., Guzmán, M., Velasco, G., & Schäfer, B. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1147 · Cited by 48
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. D. A., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., Costa, K. C. M., Campos, A. C., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06196-4 · Cited by 53
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence
Micale, V., Tabiová, K., Kučerová, J., & Drago, F. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_5 · Cited by 47
Argue, K. J., VanRyzin, J. W., Falvo, D. J., Whitaker, A. R., Yu, S. J., & McCarthy, M. M. (2017) · eneuro · doi:10.1523/eneuro.0344-16.2017 · Cited by 47
Abboussi, O., Tazi, A., Païzanis, E., & Ganouni, S. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.014 · Cited by 47
Life-Long Hippocampal Neurogenesis: Environmental, Pharmacological and Neurochemical Modulations
Païzanis, E., Kelaï, S., Renoir, T., Hamon, M., & Lanfumey, L. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9330-0 · Cited by 49
Wang, W., Yang, R., Hu, S., Wang, H., Ma, Z., & Yang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.041 · Cited by 44
Regulation of adult hippocampal neurogenesis: relevance to depression
Vaidya, V. A., Fernandes, K. A., & Jha, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.853 · Cited by 43
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 47
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task
MTA Neuroimaging Group, Rasmussen, J. M., Casey, B. J., van Erp, T. G. M., Tamm, L., Epstein, J. N., Buß, C., Bjork, J. M., Molina, B. S. G., Velanova, K., et al. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9438-9 · Cited by 45
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Wang, F., Zhou, H., Xia, X., Sun, Q., Wang, Y., & Cheng, B. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.06.003 · Cited by 43
Reddy, V. P., Grogan, D. P., Ahluwalia, M., Salles, É. L., Ahluwalia, P. K., Khodadadi, H., Alverson, K., Nguyen, A., Raju, S. P., Gaur, P., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00203-4 · Cited by 45
Canales, J. J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e16b6 · Cited by 41
Revenga, M. D. L. F., Fernández‐Sáez, N., Herrera‐Arozamena, C., Morales-Garcia, J. A., Alonso‐Gil, S., Pérez‐Castillo, A., Caignard, D., Rivara, S., & Rodrı́guez-Franco, M. I. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00245 · Cited by 41
A novel 5HT3 receptor–IGF1 mechanism distinct from SSRI-induced antidepressant effects
Kondo, M., Koyama, Y., Nakamura, Y., & Shimada, S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.87 · Cited by 41
Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions
Rivera, P., Romero‐Zerbo, S., Pavón, F. J., Serrano, A., López-Ávalos, M. D., Cifuentes, M., Grondona, J. M., Bermúdez‐Silva, F. J., Fernández‐Llebrez, P., de Fonseca, F. R., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07650.x · Cited by 44
Effects of addictive drugs on adult neural stem/progenitor cells
Xu, C., Loh, H. H., & Law, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2067-z · Cited by 40
Todd, S. W., Lumsden, E. W., Aracava, Y., Mamczarz, J., Albuquerque, E. X., & Pereira, E. F. R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108271 · Cited by 43
Hill, J. D., Zuluaga‐Ramirez, V., Gajghate, S., Winfield, M., & Persidsky, Y. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14387 · Cited by 42
Dyall, S. C., Mandhair, H. K., Fincham, R. E. A., Kerr, D. M., Roche, M., & Molina‐Holgado, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.055 · Cited by 40
The Endocannabinoid/Endovanilloid System and Depression
Smaga, I., Bystrowska, B., Gawliński, D., Przegaliński, E., & Filip, M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140923205412 · Cited by 40
Is there a role for young hippocampal neurons in adaptation to stress?
Dranovsky, A., & Leonardo, E. D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.007 · Cited by 37
Guo, X., Zhou, C., & Sun, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.104 · Cited by 38
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence
Rodrigues, R. J., Marques, J. M., & Köfalvi, A. (2024) · Cells · doi:10.3390/cells13221875 · Cited by 43
Psychoyos, D., & Vinod, K. Y. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1390 · Cited by 37
Sun, Y., Hong, F., Zhang, L., & Feng, L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13557 · Cited by 36
Haj‐Mirzaian, A., Amini-Khoei, H., Haj‐Mirzaian, A., Amiri, S., Ghesmati, M., Zahir, M., Shafaroodi, H., & Dehpour, A. R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.018 · Cited by 38
Intranasal Administration of Nerve Growth Factor Produces Antidepressant-Like Effects in Animals
Shi, C., Wang, L.-M., Wu, Y., Wang, P., Gan, Z.-J., Lin, K., Jiang, L., Xu, Q., & Fan, M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0183-6 · Cited by 37
Duarte, J. M. N., Nogueira, C., Mackie, K., Oliveira, C. R., Cunha, R. A., & Köfalvi, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.013 · Cited by 38
Resistance to antidepressant drugs
Willner, P., Scheel‐Krüger, J., & Belzung, C. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000066 · Cited by 36
Ostadhadi, S., Haj‐Mirzaian, A., Nikoui, V., Kordjazy, N., & Dehpour, A. R. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12518 · Cited by 36
Majdi, F., Taheri, F., Salehi, P., Motaghinejad, M., & Safari, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109371 · Cited by 37
The dentate gyrus in depression
Umschweif, G., Greengard, P., & Sagi, Y. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14640 · Cited by 40
Hua, Y., Huang, X., Zhou, L., Zhou, Q., Hu, Y. F., Luo, C., Li, F. Y., & Zhu, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1200-1 · Cited by 36
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
Wyrofsky, R. R., McGonigle, P., & Bockstaele, E. J. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.966680 · Cited by 35
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
Zhou, J., Burkovskiy, I., Yang, H.-W., Sardinha, J., & Lehmann, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00264 · Cited by 37
ElBatsh, M. M., Moklas, M. A. M., Marsden, C. A., & Kendall, D. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.009 · Cited by 35
Kochman, L. J., dos Santos, Â. A., Fornal, C. A., & Jacobs, B. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.080 · Cited by 35
Andres‐Mach, M., Haratym-Maj, A., Zagaja, M. P., Rola, R., Maj, M., Chrościńska–Krawczyk, M., & Łuszczki, J. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.028 · Cited by 35
Jockers-Scherübl, M. C., Rentzsch, J., Danker‐Hopfe, H., Radzei, N., Schürer, F., Bahri, S., & Hellweg, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.056 · Cited by 34
Jiang, H., Ke, B., Liu, J., Ma, G., Hai, K., Gong, D., Yang, Z., & Zhou, C. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003563 · Cited by 35
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats
Solbrig, M. V., Fan, Y., Hermanowicz, N. S., Morgese, M. G., & Giuffrida, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.003 · Cited by 34
Carr, R. L., Adams, A. L., Kepler, D. R., Ward, A., & Ross, M. K. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft126 · Cited by 34
Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THC
Sarne, Y. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1578366 · Cited by 34
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
Han, Q.-W., Yuan, Y., & Chen, N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109745 · Cited by 37
Giacobbe, J., Marrocu, A., Benedetto, M. G. D., Pariante, C. M., & Borsini, A. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.024 · Cited by 36
Luo, Y., Huang, L., Liao, P. S., & Jiang, R. (2021) · Neural Plasticity · doi:10.1155/2021/8643129 · Cited by 33
Keeley, R. J., Trow, J., & McDonald, R. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.024 · Cited by 33
Tang, M., He, T., Meng, Q., Broussard, J. I., Yao, L., Diao, Y., Sang, X., Liu, Q., Liao, Y., Li, Y., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400073x · Cited by 38
Hayase, T. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.31 · Cited by 32
Zhang, X., Yang, J., Chen, M., Li, L., Huan, F., Li, A., Liu, Y., Xia, Y., Duan, J., & Ma, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10286 · Cited by 32
Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users
Chye, Y., Suo, C., Yücel, M., Ouden, L. D., Solowij, N., & Lorenzetti, V. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4620-y · Cited by 32
Keeley, R. J., Trow, J., Bye, C., & McDonald, R. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.001 · Cited by 31
Wang, F., Han, J., Higashimori, H., Wang, J., Liu, J., Li, T., Yang, Y., Dong, H., Zhang, X., & Xiong, L. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18755661 · Cited by 30
Endocannabinoid-serotonin systems interaction in health and disease
Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31
Circulating endocannabinoids and psychological outcomes in women with PTSD
Botsford, C., Brellenthin, A. G., Cisler, J. M., Hillard, C. J., Koltyn, K. F., & Crombie, K. M. (2022) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2022.102656 · Cited by 29
Suetterlin, P., Williams, E. J., Chambers, D. J., Saraf, K. A., von Schack, D., Reisenberg, M., Doherty, P., & Williams, G. H. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.006 · Cited by 30
Lee, S., Kim, D. H., Yoon, S., & Ryu, J. H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.017 · Cited by 31
Cheng, Y., Su, Q., Shao, B., Cheng, J., Wang, H., Wang, L., Lin, Z., Ruan, L., Zhuge, Q., & Jin, K. (2013) · BioMed Research International · doi:10.1155/2013/392434 · Cited by 31
Stemistry: The Control of Stem Cells in Situ Using Chemistry
Davies, S. G., Kennewell, P. D., Russell, A. J., Seden, P. T., Westwood, R., & Wynne, G. M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500838d · Cited by 32
Endocannabinoids and the Brain Immune System: New Neurones at the Horizon?
Wolf, S. A., & Ullrich, O. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01672.x · Cited by 30
Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones
Khullar, V., Jain, A., & Sattari, M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2802-4 · Cited by 29
Gao, C., Wang, Q., Chung, S. K., & Shen, J. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.001 · Cited by 28
Directing Stem Cell Fate: The Synthetic Natural Product Connection.
Johnson, T. C., & Siegel, D. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00015 · Cited by 25
Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms
Engel, D. F., Bóbbo, V. C. D., Solon, C., Nogueira, G. A. S., Moura‐Assis, A., Mendes, N. F., Zanesco, A. M., Papangelis, A., Ulven, T., & Velloso, L. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68110-2 · Cited by 29
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Carli, M., Aringhieri, S., Kolachalam, S., Longoni, B., Grenno, G., Rossi, M., Gemignani, A., Fornai, F., Maggio, R., & Scarselli, M. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200818194948 · Cited by 29
Bueno, J., & Greenbaum, E. A. (2021) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c01034 · Cited by 28
Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?
Valeri, A., & Mazzon, E. (2021) · Molecules · doi:10.3390/molecules26206313 · Cited by 26
Rezayof, A., Ghasemzadeh, Z., & Sahafi, O. H. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105572 · Cited by 29
Stoll, E. A. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-12 · Cited by 29
G-protein Coupled Receptors in Stem Cell Self-Renewal and Differentiation
Kobayashi, N., Hawes, S. M., Crook, J. M., & Pébay, A. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9167-9 · Cited by 30
Tejeda-Martínez, A. R., Paredes, J. M. V., Hidalgo-Franco, G. V., Pardo-González, E., Chaparro-Huerta, V., González-Castañeda, R., & Flores-Soto, M. E. (2021) · Behavioural Neurology · doi:10.1155/2021/6651492 · Cited by 29
Inflammation increases the development of depression behaviors in male rats after spinal cord injury
Brakel, K., Aceves, M., Garza, A., Yoo, C., Escobedo, G., Panchani, N., Shapiro, L. A., & Hook, M. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100258 · Cited by 28
Behavioral characterization in MPTP/p mouse model of Parkinson’s disease
Wada, M., Ang, M. J., Weerasinghe-Mudiyanselage, P. D. E., Kim, S., Kim, J.-C., Shin, T., & Moon, C. (2021) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2002030 · Cited by 28
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 28
Kin, K., Yasuhara, T., Kameda, M., Agari, T., Sasaki, T., Morimoto, J., Okazaki, M., Umakoshi, M., Kuwahara, K., Kin, I., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.046 · Cited by 27
Wang, Y., Chang, T., Chen, Y., Zhang, R., Wang, H., Wu, W.-J., Peng, Z., & Tan, Q. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.021 · Cited by 28
Oddi, S., Fiorenza, M. T., & Maccarrone, M. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101239 · Cited by 27
Doze, V. A., & Perez, D. M. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394587-7.00005-1 · Cited by 26
Seizures increase cell proliferation in the dentate gyrus by shortening progenitor cell‐cycle length
Varodayan, F. P., Zhu, X., Cui, X., & Porter, B. E. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02244.x · Cited by 26
Andres‐Mach, M., Zagaja, M. P., Haratym-Maj, A., Rola, R., Maj, M., Haratym, J., Dudra-Jastrzębska, M., & Łuszczki, J. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050900 · Cited by 27
Metadata
- Authors
- Jiang, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-11-01
- Volume
- 115
- Issue
- 11
- Pages
- 3104-3116
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1253627
- OpenAlex
- W2097448914
- Cited by
- 527
- References
- 62
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 16 · 2021: 30 · 2020: 24 · 2019: 23 · 2018: 19 · 2017: 18 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 33 · 2012: 33
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Clinical Investigation (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Saskatchewan Health Research Foundation
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoids, HU-210, CB1 receptor, adult hippocampal neurogenesis, dentate gyrus, neural stem/progenitor cells, anxiolytic effects, antidepressant-like effects, ERK signaling, G protein signaling
- MeSH terms
- Animals, Antidepressive Agents, Arachidonic Acids, Cannabinoids, Cells, Cultured, Hippocampus, Male, Neurons, Rats, Inbred F344, Stem Cells, Dronabinol, Anti-Anxiety Agents, Signal Transduction, Rats, Wistar, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Cell Proliferation, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review